CD36 and diabetic cardiomyopathy: In our mild model of diabetic cardiomyopathy, we have shown that a greater proportion of the CD36 pool in the heart is S-acylated, and these findings were conserved across diabetic and insulin-resistant species, including rats, mice, pigs, and humans.